QQ客服 官方微博 反馈留言

	The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
	Wang, Yu; Chen, Hu; Chen, Jing; Han, Mingzhe; Hu, JianDa; Hu, Jiong; Huang, He; Lai, Yongrong; Liu, Daihong; Liu, Qifa
	2018
卷号	438页码:63-75
关键词	Minimal residual disease Donor lymphocyte infusion Targeted therapy Acute leukemia Myelodysplastic syndrome
ISSN号	0304-3835
DOI	10.1016/j.canlet.2018.08.030
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6354222
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Yu,Chen, Hu,Chen, Jing,et al. The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China[J],2018,438:63-75.
APA	Wang, Yu.,Chen, Hu.,Chen, Jing.,Han, Mingzhe.,Hu, JianDa.,...&Huang, Xiaojun.(2018).The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.,438,63-75.
MLA	Wang, Yu,et al."The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China".438(2018):63-75.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。